Nachrichten zu PHARMAGEST INTERACTIVE
|
07.11.24
|
||
|
27.09.24
|
Equasens: 2024 half-year results (GlobeNewswire)
|
|
|
02.08.24
|
Equasens: H1 2024 revenue (GlobeNewswire)
|
|
|
05.07.24
|
||
|
10.06.24
|
||
|
07.05.24
|
Equasens: Q1 2024 revenue (GlobeNewswire)
|
|
|
29.03.24
|
Equasens: 2023 Annual Results (GlobeNewswire)
|
|
|
06.02.24
|
Equasens: 2023 revenue: €219.7m, +2.6% (GlobeNewswire)
|
|
|
02.01.24
|
Equasens: Acquisition of a majority stake in DIGIPHARMACIE (GlobeNewswire)
|
|
|
27.12.23
|
Equasens: Changes in the Equasens Group Executive Committee (GlobeNewswire)
|
|
|
23.11.23
|
||
|
09.11.23
|
Equasens: Q3 2023 revenue (GlobeNewswire)
|
|
|
29.09.23
|
EQUASENS: H1 2023 Results (GlobeNewswire)
|
|
|
03.08.23
|
EQUASENS GROUP: H1 2023 revenue: up 9% to €112.62m (GlobeNewswire)
|
|
|
05.07.23
|
||
|
09.06.23
|
||
|
11.05.23
|
EQUASENS: Q1 2023 revenue: +13.96% to €56.25m (GlobeNewswire)
|
|
|
24.03.23
|
EQUASENS: 2022 Net Profit: +18.35% to €48.70m (GlobeNewswire)
|
Meistgelesene Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.